Unifying Model of Alzheimer’s Disease Proposed
Scientists have proposed a unifying explanation for Alzheimer's disease, linking widespread gene disruption to chronic stress granules.
Scientists have proposed a unifying explanation for Alzheimer's disease, linking widespread gene disruption to chronic stress granules.
A new study suggests that neuroactive steroid levels in the third trimester may predict postpartum depression risk.
CLP spoke with Peggy Lillis Foundation CEO Christian Lillis on raising C. diff awareness to improve diagnostics and public understanding.
The video-reporting service for in-vitro chemosensitivity testing uses real-time visual evidence to assess chemotherapy drug effectiveness.
CovarsaDx supported OSANG Healthcare in securing FDA clearance for the QuickFinder COVID-19/Flu Antigen Self-Test and Pro Test.
New research reveals that the saliva of pregnant women shows differences in their oral microbiome based on their levels of life stress.
Werfen's Aptiva APS IgG and IgM Reagents for antiphospholipid syndrome (APS) diagnosis address a need in autoimmune disease diagnostics.
Abbott's Alere NT-proBNP assay for Alinity i is a new tool for heart failure diagnosis, providing accurate results and improved efficiency.
The FDA granted Breakthrough Device Designation to Beckman Coulter's Access p-Tau217/β-Amyloid 1-42 plasma ratio blood test.
Researchers have identified two types of metabolic-associated fatty liver disease (MASLD), offering insights for improved diagnosis.
Healthy.io's kidney test demonstrated 96.4% sensitivity in detecting albuminuria, showcasing its potential to improve early detection of CKD.
The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.
Inflammatix's test system provides accurate infection likelihood and illness severity assessments for sepsis and acute infections.